310 related articles for article (PubMed ID: 24304685)
1. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
3. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
5. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
7. Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer.
Xia Y; Xiong N; Huang Y
J Biol Regul Homeost Agents; 2018; 32(1):21-28. PubMed ID: 29504361
[TBL] [Abstract][Full Text] [Related]
8. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
Long L; Cao Y; Tang LD
Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
[TBL] [Abstract][Full Text] [Related]
10. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.
Murakami K; Kotani Y; Shiro R; Takaya H; Nakai H; Matsumura N
Int J Clin Oncol; 2020 Jan; 25(1):51-58. PubMed ID: 31473885
[TBL] [Abstract][Full Text] [Related]
11. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
12. Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis.
Zhang C; Wang X; Anaya Y; Parodi L; Cheng L; Anderson ML; Hawkins SM
Int J Cancer; 2018 Nov; 143(10):2505-2515. PubMed ID: 30152524
[TBL] [Abstract][Full Text] [Related]
13. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM
Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
[TBL] [Abstract][Full Text] [Related]
14. Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.
Okugawa K; Hirakawa T; Ogawa S; Kaku T; Nakano H
Gynecol Oncol; 2002 Nov; 87(2):231-4. PubMed ID: 12477460
[TBL] [Abstract][Full Text] [Related]
15. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis.
Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M
Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Endometrioid Adenocarcinoma Arising in Endometriosis: A Case Report.
Nahar K; Ferdous B; Akhter N; Shamsunnahar PA; Khatun K; Begum SA; Aziz MA
Mymensingh Med J; 2018 Apr; 27(2):420-423. PubMed ID: 29769513
[TBL] [Abstract][Full Text] [Related]
17. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.
Murakami K; Kotani Y; Nakai H; Matsumura N
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599890
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis.
Ren F; Wang D; Jiang Y; Ren F
Arch Gynecol Obstet; 2012 Jan; 285(1):215-21. PubMed ID: 21556900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
